EP Patent

EP2214652A2 — Gastrointestinal delivery systems

Assigned to Meritage Pharma Inc · Expires 2010-08-11 · 16y expired

What this patent protects

Provided herein are compositions suitable for the delivery of therapeutic agents to the gastrointestinal tract. Also provided herein are methods for treating, preventing or alleviating disorders of the gastrointestinal tract, for example, those involving the esophagus, by orally …

USPTO Abstract

Provided herein are compositions suitable for the delivery of therapeutic agents to the gastrointestinal tract. Also provided herein are methods for treating, preventing or alleviating disorders of the gastrointestinal tract, for example, those involving the esophagus, by orally administering compositions described herein.

Drugs covered by this patent

Patent Metadata

Patent number
EP2214652A2
Jurisdiction
EP
Classification
—
Expires
2010-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Meritage Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.